Objective: This study aimed to evaluate the short-term curative e ect of computed tomography (CT) guided radioactive 125I (125Iodine) seed implantation (CTRISI) therapy for advanced pancreatic cancer patients pain. Study Design: Interventional study. Place and Duration of Study: Imaging Department and Oncology Department, First A liated Hospital of Zhengzhou University, China, from January 2015 to March 2017. Methodology: A total of thirty-seven patients with advanced pancreatic cancer pain who underwent CTRISI were enrolled.Exclusion criteria were coagulation disorder, multi-organ failure, co-existent pancreatitis and/or uncontrolled hyperglycemia. Cancer pain levels and daily hydroxycodone dose were compared before and after CTRISI, using the Numerical Rating Scale (NRS). Complication after procedure were also noted. Results: All patients were successfully implanted with 125I seeds via CT. After 1-week, 1-month and 2-month of implantation, the NRS scores were signi cantly lower than preoperative scoresp<(0.05). The daily dose of hydroxycodone in one week and one month after operation were signi cantly lower than preoperation (p<0.001). However, after 2-month of implantation, the daily hydroxycodone dose was not di erent from the preoperative dose (p=0.198). No patient experienced serious complications. Conclusion: CTRISI could relieve pain e ectively in the patients and suppress local tumor progress. This technique helps to relieve the pain symptoms, reduce the amount of painkillers, and improve the quality of life of patients.